GBA1 and Parkinson disease: We have further shown that chemical inhibition of cathepsin L in an iPSC dopaminergic neuronal PD model of GBA1 haploinsufficiency partially corrected reduced GCase protein level and led to reduction of pS129-α-synuclein.